Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN ‐amplified neuroblastoma-Reference-Cited by-同舟云学术

Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN ‐amplified neuroblastoma

Published:2021-07-31 Issue:10 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Shahid Sanam¹^ORCID,Kushner Brian H.¹,Modak Shakeel¹,Basu Ellen M.¹,Rubin Elyssa M.²,Gundem Gunes³,Papaemmanuil Elli³,Roberts Stephen S.¹^ORCID

Affiliation:

1. Department of Pediatrics Memorial Sloan Kettering Cancer Center New York New York

2. Department of Pediatric Oncology CHOC Children's Orange California

3. Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York New York

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29265

Reference21 articles.

1. Neuroblastoma

2. Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma

3. VIP hypersecretion as primary or secondary syndrome in neuroblastoma: a retrospective study by the Société Française des Cancers de l'Enfant;Bourdeaut F;SFCE,2009

4. Uncommon reasons of the digestive tract‐related paraneoplastic syndromes in children with neuroblastic tumors: three case reports;Czkwianianc E;Contemp Oncol (Pozn),2018

5. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasoactive Intestinal Peptide-Producing Neuroblastic Tumors: A Rare Cause of Refractory Diarrhea;Cureus;2024-08-26

2. MEK-inhibitors decrease Nfix in muscular dystrophy but induce unexpected calcifications, partially rescued with Cyanidin diet;iScience;2024-01

3. Precision based approach to tailoring radiotherapy in the multidisciplinary management of pediatric central nervous system tumors;Journal of the National Cancer Center;2023-06

4. The Role of Ketogenic Diet in the Treatment of Neuroblastoma;Integrative Cancer Therapies;2023-01

5. Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma;Current Pharmacology Reports;2022-12-31